未登录

V

Vivian B. Neis

universidade federal de santa catarina(ufsc)

H指数:27

被引数:1,835

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice

METABOLIC BRAIN DISEASE

IF3.5

2022-04-186

PRE

Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling

PURINERGIC SIGNALLING

IF2.4

2021-03-1317

OAAI

The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2020-11-0131

PREAI

Cholecalciferol abolishes depressive-like behavior and hippocampal glucocorticoid receptor impairment induced by chronic corticosterone administration in mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2020-09-0123

PREAI

The involvement of GABAergic system in the antidepressant-like effect of agmatine

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2020-05-2313

PRE

A single coadministration of subeffective doses of ascorbic acid and ketamine reverses the depressive-like behavior induced by chronic unpredictable stress in mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2019-12-0118

PREAI

The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways

PURINERGIC SIGNALLING

IF2.4

2019-11-2528

OAAI

Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2019-08-2819

PREAI

Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway

JOURNAL OF PSYCHIATRIC RESEARCH

IF3.2

2019-08-0138

PREAI

Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2018-10-0126

PREAI

Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2018-02-0136

OAAI

Evidence for the involvement of opioid system in the antidepressant-like effect of ascorbic acid

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2017-12-0812

PREAI

Therapeutic potential of agmatine for CNS disorders

NEUROCHEMISTRY INTERNATIONAL

IF4

2017-09-0152

PREAI

Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test

JOURNAL OF NEURAL TRANSMISSION

IF4

2017-07-1020

PREAI

Signaling pathways underlying the antidepressant-like effect of inosine in mice

PURINERGIC SIGNALLING

IF2.4

2016-12-1337

OAAI

Agmatine, a potential novel therapeutic strategy for depression

Agmatine，一种潜在的抑郁症新治疗策略

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-12-0140

PREAI

Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2016-11-0140

OAAI

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors

PHARMACOLOGICAL REPORTS

IF3.8

2016-10-0161

PREAI

Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling

Agmatine通过激活AMPA受体和mTOR信号产生抗抑郁样作用

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-06-0158

PREAI

Intracellular signaling pathways implicated in the antidepressant-like effect of ursolic acid in the tail suspension test

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2015-09-010

PREAI